Bandingkan Harga & Kinerja Organon Pharma Indonesia Tbk. (SCPI) vs Saraswanti Indoland Development Tbk. (SWID)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Organon Pharma Indonesia Tbk. dan Saraswanti Indoland Development Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Saraswanti Indoland Development Tbk. diperdagangkan di Rp117 (kapitalisasi pasar 635,43 M, volume 24 jam 2,92 jt). Perbedaan utamanya: Saraswanti Indoland Development Tbk. jauh lebih besar — sekitar 6,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | SWID | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 635,43 M |
Volume | — | 2,92 jt |
Lot | — | 29,25 rb |
Perputaran | — | 343,27 jt |
Harga Rata-rata | — | 117,38 |
Nilai Transaksi | — | 343,27 jt |
Harga Ekuilibrium Indikatif | — | 117 |
Volume Ekuilibrium Indikatif | — | 121 |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →Tentang Saraswanti Indoland Development Tbk.
PT Saraswanti Indoland Development Tbk ( The Company) was established on August 2, 2010 based on the Deed of Notary Ismaryani, SH, MKn. Number : 01. The deed of establishment of the Company was approved by the Minister of Law and Human Rights of the Republic of Indonesia number: AHU41610.AH.01.01.Tahun 2010. The Company started its commercial operations in 2011.
Selengkapnya di halaman SWID →
